Lovastatin-Induced Lupus Erythematosus

Archives of Internal Medicine

Volumn 151, Issue 8, 1991, Pages 1667-1668

  Ahmad, Saeed ^a  

^a Cardio Diagnostic Clinique ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEVINOLIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CASE REPORT; FEMALE; HUMAN; LOVASTATIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE;

EID: 0025812396     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1991.00400080147030     Document Type: Article

References (10)

1. Kaposi M. Neue Beitrage zur Kenntnis des Lupus erythematosus. Arch Dermatol Syphilol. 1872;4:36-78.
2. Osler W. On the visceral complications of erythema exudative multiforme. Am J Med Sci. 1895;110:629.
3. Harvey AM, Shulman LE, Tumulty PA, et al. Systemic Lupus Erythematosus: Review of the Literature and Clinical Analysis of 138 Cases. Baltimore, Md: Williams & Wilkins; 1955.
4. Tobert JA, Shear CL, Chremos AN, Mantell GE. Clinical experience with lovastatin. Am J Cardiol. 1990;65:23F-26F.
5. Mantell G, Burke MT, Staggers J. Extended clinical safety profile of lovastatin. Am J Cardiol. 1990;66:11B-15B.
6. Weinstein A. Drug induced systemic lupus erythematosus. Prog Clin Immunol. 1980;4:1-21.
7. Schwartz D, Pines A, Averbuch M, Levo Y. Enalapril-induced antinuclear antibodies. Lancet. 1990;336:187.
8. Dalen JE. Lowering serum cholesterol: it is time to proceed. Arch Intern Med. 1988;148:34-35.
9. Dalen JE. Detection and treatment of elevated blood cholesterol: what have we learned? Arch Intern Med. 1991;151:25-28.
10. Ahmad S. Lovastatin-warfarin interaction. Arch Intern Med. 1990;150:2407.